Back to Search
MARK DECKER, MD
MD
Diagnostic Radiology Physician
NPI: 1023002862IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
206944(NY)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Class of 1993
Research & Publications (20)
Coupling effects in low-symmetry planar split-ring resonator arrays.
PMID 19448827·Opt Lett·2009
8-other
Contacting the brain--aspects of a technology assessment of neural implants.
PMID 19072906·Biotechnol J·2008
8-other
Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.
PMID 18343673·Bioorg Med Chem·2008
7-preclinical
Reaching youth through franchise clinics: assessment of Kenyan private sector involvement in youth services.
PMID 17321432·J Adolesc Health·2007
8-other
Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties.
PMID 17346215·Mini Rev Med Chem·2007
6-review
Agonistic and antagonistic bivalent ligands for serotonin and dopamine receptors including their transporters.
PMID 17305576·Curr Top Med Chem·2007
6-review
LE300--new results on its ability to antagonize the discriminative stimulus effects of cocaine.
PMID 16599272·Pharmazie·2006
7-preclinical
Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.
PMID 16942014·J Med Chem·2006
8-other
Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
PMID 16289855·Bioorg Med Chem·2006
7-preclinical
Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine.
PMID 15725500·Eur J Med Chem·2005
7-preclinical
Synthesis and vasorelaxant properties of hybrid molecules out of NO-donors and the beta-receptor blocking drug propranolol.
PMID 15341967·Bioorg Med Chem Lett·2004
7-preclinical
Dopamine/serotonin receptor ligands. Part VIII: the dopamine receptor antagonist LE300 - modelled and X-ray structure plus further pharmacological characterization, including serotonin receptor binding, biogenic amine transporter testing and in vivo testings.
PMID 15183906·Eur J Med Chem·2004
8-other
Dopamine receptor ligands. Part VII [1]: novel 3-substituted 5-phenyl-1, 2, 3, 4, 5, 6-hexahydro-azepino-[4, 5-b]indoles as ligands for the dopamine receptors.
PMID 14582123·Arch Pharm (Weinheim)·2003
7-preclinical
Intimate partner violence perpetration, standard and gendered STI/HIV risk behaviour, and STI/HIV diagnosis among a clinic-based sample of men.
PMID 19625287·Sex Transm Infect·2009
4-observational
Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.
PMID 19634902·J Med Chem·2009
7-preclinical
Maternal experiences of intimate partner violence and child morbidity in Bangladesh: evidence from a national Bangladeshi sample.
PMID 19652100·Arch Pediatr Adolesc Med·2009
8-other
WITHDRAWN: Design and synthesis of pivalic acid linked tacrine-NO donor hybrids as novel anti-Alzheimer drug candidates.
PMID 19679473·Bioorg Med Chem Lett·2009
8-other
HIV vulnerabilities of sex-trafficked Indian women and girls.
PMID 19625022·Int J Gynaecol Obstet·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 E SUNRISE HWY, 208
LINDENHURST, NY 11757 - Phone
- (631) 225-7200
Quick Facts
- NPI
- 1023002862
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile